| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.29 | 0.3 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |